Early experience with delamanid-containing regimens in the treatment of complicated multidrug-resistant tuberculosis in Hong Kong Source: Eur Respir J, 51 (6) 1800159; 10.1183/13993003.00159-2018 Year: 2018
Characterisation of patients hospitalised for asthma exacerbations in Hong Kong Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020
Frequency of chronic pulmonary aspergillosis in patients treated for pulmonary tuberculosis at a tertiary care hospital in Karachi, Pakistan. Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021
Home mechanical ventilation in Hong Kong Source: Eur Respir J 2004; 23: 136-141 Year: 2004
Drug resistance trends and patterns of mycobacterium tuberculosis isolates from pulmonary tuberculosis patients at a tertiary care hospital in Turkey Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012
Drug resistant tuberculosis among Greek and immigrant patients in a pulmonary department in northern Greece Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011
Alternate diagnosis in clinically diagnosed pulmonary tuberculosis patients treated at tertiary care hospital in a high TB burden country Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020
The prevalence of initial drug resistance among pulmonary tuberculosis patients at one tertiary hospital in Cheonan, Korea Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008
Treatment outcome of MDR pulmonary tuberculosis in a tertiary care hospital of Karachi, Pakistan Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Declining asthma prevalence in Hong Kong Chinese children? Source: Annual Congress 2003 - Epidemiological aspects of childhood asthma Year: 2003
Pulmonary tuberculosis in the Republic of Ireland (1991–2001): outcome and experience in a specialist unit Source: Eur Respir J 2006; 28: Suppl. 50, 304s Year: 2006
The increasing trend of nontuberculous mycobacterial pulmonary diseases in a tertiary referral hospital in South Korea between 2006 and 2016 Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019
12-year time trend of the prevalence of respiratory symptoms, asthma, chronic bronchitis and emphysema in the elderly Chinese living in Hong Kong Source: Eur Respir J 2005; 26: Suppl. 49, 378s Year: 2005
A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate? Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
The prevalence of bronchitis and associations with spirometry in patients with interstitial lungdisease in a Canadian tertiary care centre Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019
Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
Prevalence of sleep-disordered breathing in COPD patients in Hong Kong Source: Eur Respir J 2001; 18: Suppl. 33, 256s Year: 2001
Variability in access and referral to pulmonary rehabilitation in European bronchiectasis patients enrolled in the EMBARC registry Source: International Congress 2018 – Latest advances in pulmonary rehabilitation assessment and content Year: 2018
Seasonality of primary care utilization for asthma, COPD and pneumonia in Karachi (Pakistan) Source: Annual Congress 2012 - Epidemiology of asthma Year: 2012